Tiagabine Hydrochloride
C20H25NO2S2·HCl
412.00
3-Piperidinecarboxylic acid, 1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-, hydrochloride, (R)-;
(−)-(R)-1-[4,4-Bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid, hydrochloride
[145821-59-6] Free base
C20H25NO2S2 375.55
[115103-54-3] Monohydrate C20H25NO2S2·HCl·H2O 430.02
[145821-57-4]
3-Piperidinecarboxylic acid, 1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-, hydrochloride, (R)-;
(−)-(R)-1-[4,4-Bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid, hydrochloride
[145821-59-6] Free base
C20H25NO2S2 375.55
[115103-54-3] Monohydrate C20H25NO2S2·HCl·H2O 430.02
[145821-57-4]
DEFINITION
Tiagabine Hydrochloride contains NLT 97.5% and NMT 102.5% of tiagabine hydrochloride (C20H25NO2S2·HCl), calculated on the anhydrous basis.
USP REFERENCE STANDARDS FOR PURCHASE
USP Racemic Tiagabine Hydrochloride Mixture RSUSP Tiagabine Hydrochloride RS
USP Tiagabine Related Compound A RS